North Peak Capital Management, LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
North Peak Capital Management, LLC disclosed 8 US equity positions worth $900.0m in its Q2 2026 13F filing. The largest position was HGV at 25.9% of the reported book, followed by AGL and SCHW. Against the Q1 2026 filing, it opened 2 new positions, added to 4 and reduced 2 among the top 8 holdings.
What did North Peak Capital Management, LLC own in Q2 2026? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 25.9% | $233.2m | 4,452,472 | 1% | added |
| 2 | AGL AGILON HEALTH INC | 17.7% | $159.2m | 1,485,066 | -4% | reduced | |
| 3 | SCHW SCHWAB CHARLES CORP | Financial Services | 16.9% | $151.9m | 1,646,358 | 37% | added |
| 4 | CVNA CARVANA CO | Consumer Cyclical | 16.9% | $151.8m | 2,306,869 | 448% | added |
| 5 | SE SEA LTD | Consumer Cyclical | 8.0% | $72.3m | 754,618 | 24% | added |
| 6 | FIGR FIGURE TECHNOLOGY SOLUTIO | Financial Services | 7.9% | $70.9m | 2,307,148 | – | new |
| 7 | CELH CELSIUS HLDGS INC | Consumer Defensive | 3.9% | $35.0m | 1,195,244 | – | new |
| 8 | HAE HAEMONETICS CORP MASS | Healthcare | 2.9% | $25.7m | 343,077 | -66% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.